Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Agracheva, A"'
Autor:
Pappalardo, Federico *, ⁎, Agracheva, Nataliya *, Covello, Remo Daniel *, Pieri, Marina *, De Bonis, Michele †, Calabrò, Maria Grazia *, Koster, Andreas ‡, Zangrillo, Alberto *
Publikováno v:
In Journal of Cardiothoracic and Vascular Anesthesia August 2014 28(4):1013-1017
Autor:
Pieri, M., Agracheva, N., Fumagalli, L., Greco, T., De Bonis, M., Calabrese, M.C., Rossodivita, A., Zangrillo, A., Pappalardo, F.
Publikováno v:
In Medicina Intensiva (English Edition) October 2013 37(7):468-475
Autor:
Pieri, Marina, Agracheva, Natalia, Bonaveglio, Enrico, Greco, Teresa, De Bonis, Michele, Covello, Remo Daniel, Zangrillo, Alberto, Pappalardo, Federico
Publikováno v:
In Journal of Cardiothoracic and Vascular Anesthesia February 2013 27(1):30-34
Autor:
N. Agracheva, Marina Pieri, Andreas Koster, Alberto Zangrillo, Remo Daniel Covello, Michele De Bonis, Maria Grazia Calabrò, Federico Pappalardo
Publikováno v:
Journal of Cardiothoracic and Vascular Anesthesia. 28:1013-1017
OBJECTIVE: Anticoagulation with unfractionated heparin (UFH) in critically ill cardiac surgery patients has several limitations, including the risk of heparin-induced thrombocytopenia. The use of a direct thrombin inhibitor, such as bivalirudin, migh
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d8b5c72b422ca16d789390afe6b92396
https://doi.org/10.1053/j.jvca.2013.10.004
https://doi.org/10.1053/j.jvca.2013.10.004
Autor:
Marina Pieri, Teresa Greco, Alberto Zangrillo, Enrico Bonaveglio, Federico Pappalardo, Remo Daniel Covello, Natalia Agracheva, Michele De Bonis
Publikováno v:
Journal of Cardiothoracic and Vascular Anesthesia. 27:30-34
Objective: Heparin-based anticoagulation for patients undergoing extracorporeal membrane oxygenation has many limitations, including a high risk of heparin-induced thrombocytopenia. However, little experience with other anticoagulants in these patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d075c41bbc0d52d920219d447c7e8b33
https://doi.org/10.1053/j.jvca.2012.07.019
https://doi.org/10.1053/j.jvca.2012.07.019
Autor:
Pieri, Marina1, Agracheva, Natalia1, Di Prima, Ambra Licia1, Nisi, Teodora2, De Bonis, Michele2, Isella, Francesca1, Zangrillo, Alberto1, Pappalardo, Federico1
Publikováno v:
Artificial Organs. Apr2014, Vol. 38 Issue 4, p342-346. 5p.
Autor:
Marina Pieri, Laura Ruggeri, M. G. Calabrò, OG Turla, Alberto Zangrillo, Federico Pappalardo, N. Agracheva
Publikováno v:
Perfusion. 28:132-137
Phosphorylcholine coating has a major role in the improvement of biocompatibility, durability and antihrombogenicity of the circuit for extracorporeal membrane oxygenation (ECMO). Moreover, if heparin-induced thrombocytopenia ensues, removal of all t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ddf1eb2fbc0df66cda8fac806e2a53d8
https://doi.org/10.1177/0267659112469642
https://doi.org/10.1177/0267659112469642
Autor:
Malgorzata Celinska-Spodar, Martina Crivellari, Daiana Taddeo, Giovanni Landoni, N. Agracheva, Federico Pappalardo, Alberto Zangrillo, Rosalba Lembo, Ambra Licia Di Prima
URPOSE:To determine whether protein C zymogen (protein C concentrates or human protein C) improves clinically relevant outcomes in adult patients with severe sepsis and septic shock.METHODS:This is a randomized, double-blind, placebo-controlled, para
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2c602330f62a85ed884ad542f5a72d14
Autor:
Natalia Agracheva, Alberto Zangrillo, Francesca Isella, Michele De Bonis, Teodora Nisi, Marina Pieri, Federico Pappalardo, Ambra Licia Di Prima
Publikováno v:
Artificial Organs. 38:342-346
Bivalirudin is a direct thrombin inhibitor that is increasingly used in patients undergoing mechanical circulatory support as it presents many advantages compared with unfractionated heparin. The aim of this study was to describe our experience with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1fb56cff391c2b2d607fd7aec6c98b62
https://doi.org/10.1111/aor.12168
https://doi.org/10.1111/aor.12168
Autor:
Pieri M, Agracheva N, Di Prima AL, Nisi T, Isella F, DE BONIS, MICHELE, ZANGRILLO, ALBERTO, PAPPALARDO, FEDERICO
Bivalirudin is a direct thrombin inhibitor that is increasingly used in patients undergoing mechanical circulatory support as it presents many advantages compared with unfractionated heparin. The aim of this study was to describe our experience with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od_____10495::b5a57d633f4ae8d193fb1afca2235f02